Novel appearance of hyperglycemia/diabetes, associated with COVID-19.
World J Virol
; 11(2): 111-112, 2022 Mar 25.
Article
in English
| MEDLINE | ID: covidwho-1791987
ABSTRACT
In a recent meta-analysis the prevalence of coronavirus disease 2019 (COVID-19)-associated hyperglycemia was 25%, and that of COVID-19-associated new-onset diabetes was 19%. An association between hyperglycemia or new-onset diabetes and COVID-19 has been suggested. In a recent relevant study of critically and non-critically ill patients with COVID-19, we found that indeed beta-cell function was compromised in critically ill patients with COVID-19 and that these patients showed a high glycemic gap. Nevertheless, one quarter of critically ill patients with no history of diabetes have stress hyperglycemia, a finding which could obscure the prevalence of hyperglycemia or new-onset diabetes that could be attributed to COVID-19 per se.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
/
Reviews
Language:
English
Journal:
World J Virol
Year:
2022
Document Type:
Article
Affiliation country:
Wjv.v11.i2.111
Similar
MEDLINE
...
LILACS
LIS